Want to see JP:6523 full AI Analyst Report?
Top Page
PHC Holdings Corp.
(6523)
Select Model
Select Model
Rating:64Neutral
Price Target:
¥1,802.00
▲(62.05% Upside)
Action:Reiterated
Date:10/02/26
The score is driven primarily by mixed financial performance: strong operating and free cash flow, but weak and volatile net profitability and still-meaningful leverage. Technicals are a notable positive with a strong uptrend and supportive momentum. Valuation is moderate-to-demanding (P/E ~23) relative to current earnings quality, partly balanced by a ~2.5% dividend yield.
Positive Factors
Recurring consumables and services
The mix of disposable consumables and after-sales services can create repeat purchasing beyond one-time equipment sales. An installed base of diagnostic, diabetes, and healthcare equipment may therefore support customer retention and more durable revenue visibility.
Negative Factors
Near-breakeven net profitability
Very thin and inconsistent net margins leave little buffer against operating, financing, or other costs. Prior losses also show that positive operating profitability has not yet translated into durable bottom-line earnings, limiting internal compounding capacity.
Read all positive and negative factors
Positive Factors
Negative Factors
Recurring consumables and services
The mix of disposable consumables and after-sales services can create repeat purchasing beyond one-time equipment sales. An installed base of diagnostic, diabetes, and healthcare equipment may therefore support customer retention and more durable revenue visibility.
Read all positive factors
PHC Holdings Corp. (6523) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥182.08B
Dividend Yield2.49%
Average Volume (3M)724.03K
Price to Earnings (P/E)23.2
Beta (1Y)0.76
Revenue Growth3.04%
EPS Growth-19.26%
CountryJP
Employees8,647
SectorHealthcare
Sector Strength45
IndustryMedical - Devices
Share Statistics
EPS (TTM)72.45
Shares Outstanding127,327,580
10 Day Avg. Volume593,600
30 Day Avg. Volume724,033
Financial Highlights & Ratios
PEG Ratio-2.94
Price to Book (P/B)0.85
Price to Sales (P/S)0.38
P/FCF Ratio4.13
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)160.04
Revenue Forecast (FY)¥372.57B
PHC Holdings Corp. Business Overview & Revenue Model
Company Description
PHC Holdings Corporation, through its network of subsidiaries, specializes in the innovation, production, and sale of medical instruments, advanced healthcare technology solutions, and life science merchandise. The company's product line includes ...
How the Company Makes Money
PHC Holdings primarily makes money by selling healthcare and life-science products and related consumables to hospitals, clinics, laboratories, research institutions, and distributors, generating revenue from both (1) capital equipment sales and (...
PHC Holdings Corp. Financial Statement Overview
Summary
Income Statement
54
Neutral
Balance Sheet
47
Neutral
Cash Flow
72
Positive
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 371.22B | 364.40B | 361.59B | 353.90B | 356.43B | 340.45B |
| Gross Profit | 170.27B | 165.26B | 166.22B | 157.97B | 169.13B | 165.24B |
| EBITDA | 54.54B | 47.72B | 52.33B | 30.15B | 36.76B | 37.56B |
| Net Income | 9.17B | 492.00M | 10.48B | -12.89B | -3.22B | -8.46B |
Balance Sheet | ||||||
| Total Assets | 543.08B | 542.51B | 532.48B | 564.33B | 561.57B | 591.32B |
| Cash, Cash Equivalents and Short-Term Investments | 41.28B | 39.82B | 43.90B | 51.82B | 63.25B | 97.63B |
| Total Debt | 229.26B | 234.56B | 269.26B | 300.28B | 307.24B | 323.32B |
| Total Liabilities | 374.61B | 381.63B | 391.31B | 425.16B | 422.74B | 455.25B |
| Stockholders Equity | 169.31B | 161.67B | 141.64B | 139.51B | 138.01B | 135.37B |
Cash Flow | ||||||
| Free Cash Flow | 41.83B | 33.37B | 30.33B | 26.67B | 9.86B | 39.32B |
| Operating Cash Flow | 51.41B | 42.46B | 41.94B | 41.30B | 21.38B | 51.05B |
| Investing Cash Flow | -9.70B | -8.45B | -8.47B | -23.68B | -17.52B | -12.52B |
| Financing Cash Flow | -39.29B | -39.82B | -39.07B | -36.53B | -40.83B | -7.01B |
PHC Holdings Corp. Technical Analysis
Positive
1112.00
Price Trends
1310.01
Positive
1170.39
Positive
1110.92
Positive
Market Momentum
45.41
Negative
76.28
Negative
85.76
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6523, the sentiment is Positive. The current price of 1112 is below the 20-day moving average (MA) of 1376.54, below the 50-day MA of 1310.01, and above the 200-day MA of 1110.92, indicating a bullish trend. The MACD of 45.41 indicates Negative momentum. The RSI at 76.28 is Negative, neither overbought nor oversold. The STOCH value of 85.76 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:6523.
PHC Holdings Corp. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥17.35B | 11.45 | ― | 6.37% | 20.88% | 44.61% | |
64 Neutral | ¥182.08B | 23.24 | 5.76% | 2.49% | 3.04% | -19.26% | |
64 Neutral | ¥8.84B | 10.52 | ― | 2.78% | 9.02% | 8.88% | |
63 Neutral | ¥262.55B | 19.23 | ― | 1.99% | 1.43% | 1.86% | |
57 Neutral | ¥76.09B | 21.40 | ― | 2.51% | 2.94% | 57.05% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
47 Neutral | ¥16.75B | -73.48 | ― | 2.76% | -6.64% | 67.08% |
* Healthcare Sector Average
JP:6523
PHC Holdings Corp.
1,684.00
752.38
80.76%
JP:4549
Eiken Chemical Co., Ltd.
2,307.00
26.49
1.16%
JP:6678
Techno Medica Co., Ltd.
2,024.00
162.37
8.72%
JP:6849
Nihon Kohden Corporation
1,609.50
-34.05
-2.07%
JP:7600
Japan Medical Dynamic Marketing, Inc.
615.00
135.51
28.26%
JP:7963
Koken Ltd.
1,800.00
82.90
4.83%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.